9 3 5213 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)
Pill with imprint 9 3 5213 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg. It is supplied by Teva Pharmaceuticals USA.
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 9 3 5213
Hydrochlorothiazide and Moexipril Hydrochloride
- Imprint
- 9 3 5213
- Strength
- 12.5 mg / 7.5 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- ACE inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
lactose monohydrate, magnesium stearate, povidone k30, sodium bicarbonate, polyethylene glycol 3350, magnesium silicate, titanium dioxide, FD&C Yellow No. 5, FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-5213 | Teva Pharmaceuticals USA, Inc. |
| 42291-0576 | AvKare, Inc. |
More about hydrochlorothiazide / moexipril
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 1 Review
- Drug class: ACE inhibitors with thiazides
- FDA Alerts (1)
Consumer resources
Other brands: Uniretic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
